Biomarkers for Oncology
JH · Effective Oct 1, 2015
138 active Medicare policies list C76.0, and 15 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 138
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective May 28, 2023
J9 · Effective Jul 11, 2021
JH · Effective Oct 1, 2015
15 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 13 · All Aetna policies
| Policy | Effective | Status of C76.0 |
|---|---|---|
| Carbogen Inhalation Therapy | Jun 8, 2023 | Covered |
| Cerebral Perfusion Studies | Sep 14, 2023 | Covered |
| Dendritic Cell Immunotherapy | Jun 6, 2023 | Covered |
| Hyperthermia in Cancer Therapy | Feb 9, 2024 | Covered |
| Intraoperative Neurophysiological Monitoring | Oct 26, 2023 | Covered |
| Intraoperative Radiation Therapy (IORT) | Sep 22, 2023 |
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Nov 14, 2021
J8 · Effective Nov 14, 2021
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Jul 15, 2026
JK · Effective Jul 15, 2026
JJ · Effective Jul 24, 2022
JM · Effective Jul 24, 2022
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Jan 22, 2023
JM · Effective Jan 22, 2023
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J5 · Effective Mar 15, 2020
J8 · Effective Mar 15, 2020
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J15 · Effective Oct 24, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Dec 3, 2023
JM · Effective Dec 3, 2023
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2025
National · Effective Oct 1, 2025
JL · Effective Nov 17, 2025
National · Effective Jan 1, 2026
J9 · Effective Nov 17, 2025
J5 · Effective Jan 1, 2026
National · Effective Nov 27, 2025
National · Effective Oct 1, 2025
National · Effective Jan 1, 2024
National · Effective Apr 1, 2025
| Jaw Motion Rehabilitation Systems | Jun 7, 2023 | Covered |
|---|
| Magnetic Resonance Angiography (MRA) and Magnetic Resonance Venography (MRV) | Mar 23, 2023 | Covered |
|---|
| Panitumumab (Vectibix) | Feb 5, 2024 | Covered |
|---|
| Pharmacogenetic and Pharmacodynamic Testing | Feb 27, 2024 | Covered |
|---|
| Policy | Effective | Status of C76.0 |
|---|---|---|
| Head and Neck Ultrasound | Sep 15, 2026 | Covered |
| Low-Level Laser and High-Power Laser Therapy | Mar 15, 2026 | Covered |